The family behind Purdue Pharma reportedly doesn’t want to sacrifice a bigger chunk of their personal wealth to settle the thousands of opioid-related lawsuits related to their crown jewel, OxyContin. But that might put them in the crosshairs of even more lawsuits. For awhile it looked like the Sackler clan was willing to come to the table and make a deal if they could skip a blockbuster trial scheduled for next month in Ohio.